Fresenius Medical Care AG & Co KGaA (FME):企業の財務・戦略的SWOT分析

◆英語タイトル:Fresenius Medical Care AG & Co KGaA (FME) - Financial and Strategic SWOT Analysis Review
◆商品コード:GDPH700FSA
◆発行会社(調査会社):GlobalData
◆発行日:2021年4月
◆ページ数:62
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:ドイツ
◆産業分野:Pharmaceuticals and Healthcare
◆販売価格オプション(消費税別)
Site License(同一事業所内共有可)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD375 ⇒換算¥55,500見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Fresenius Medical Care AG & Co KGaA (FME) – Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.
The profile contains critical company information including:

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

Fresenius Medical Care AG & Co KGaA (Fresenius Medical Care), a subsidiary of Fresenius SE & Co KGaA, is an integrated dialysis company. It provides dialysis care services and products to individuals with chronic kidney failure. It develops and manufactures a comprehensive range of dialysis machines, systems and disposable products. The company also offers Care Coordination services including pharmacy services, vascular, cardiovascular and endovascular specialty services, non-dialysis laboratory testing services, physician services, hospitalist and intensivist services, health plan services and urgent care services. The company provides dialysis treatment at its clinics and also sells its products to other dialysis service providers. It conducts its operations through its subsidiaries in Europe, the Middle East, Africa, the Americas and Asia-Pacific. Fresenius Medical Care is headquartered in Bad Homburg, Germany.

Fresenius Medical Care AG & Co KGaA Key Recent Developments

Apr 13,2021: Fresenius Medical Care opens new technology center in Schweinfurt for developing dialysis machines
Mar 12,2021: Fresenius Medical Care makes company’s dialysis clinics available for vaccinating patients against COVID-19
Feb 23,2021: Fresenius Medical Care achieves 2020 targets, expects significant COVID-19 impact in 2021 and confirms 2025 outlook
Feb 01,2021: Fresenius Medical Care anticipates significant negative impact on 2021 net income from accelerated COVID-19 related excess mortality of dialysis patients; confirms mid-term targets
Jan 11,2021: Fresenius Medical Care’s Frenova enrolls patients in initiative to build world’s largest genomic registry targeting kidney disease

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company

【レポートの目次】

Table of Contents
List of Tables
List of Figures
Section 1 – About the Company
Fresenius Medical Care AG & Co KGaA – Key Facts
Fresenius Medical Care AG & Co KGaA – Key Employees
Fresenius Medical Care AG & Co KGaA – Key Employee Biographies
Fresenius Medical Care AG & Co KGaA – Major Products and Services
Fresenius Medical Care AG & Co KGaA – History
Fresenius Medical Care AG & Co KGaA – Company Statement
Fresenius Medical Care AG & Co KGaA – Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Section 2 – Company Analysis
Company Overview
Fresenius Medical Care AG & Co KGaA – Business Description
Business Segment: Health Care Products
Overview
Performance
Business Segment: Health Care Services
Overview
Performance
Key Stats
Geographical Segment: Asia-Pacific
Performance
Geographical Segment: Corporate
Performance
Geographical Segment: EMEA
Performance
Geographical Segment: Latin America
Performance
Geographical Segment: North America
Performance
R&D Overview
Fresenius Medical Care AG & Co KGaA – Corporate Strategy
Fresenius Medical Care AG & Co KGaA – SWOT Analysis
SWOT Analysis – Overview
Fresenius Medical Care AG & Co KGaA – Strengths
Fresenius Medical Care AG & Co KGaA – Weaknesses
Fresenius Medical Care AG & Co KGaA – Opportunities
Fresenius Medical Care AG & Co KGaA – Threats
Fresenius Medical Care AG & Co KGaA – Key Competitors
Section 3 – Company Financial Ratios
Financial Ratios – Capital Market Ratios
Financial Ratios – Annual Ratios
Performance Chart
Financial Performance
Financial Ratios – Interim Ratios
Financial Ratios – Ratio Charts
Section 4 – Company’s Lifesciences Financial Deals and Alliances
Fresenius Medical Care AG & Co KGaA, Pharmaceuticals & Healthcare, Deals By Year, 2015 to YTD 2021
Fresenius Medical Care AG & Co KGaA, Pharmaceuticals & Healthcare, Deals By Type, 2015 to YTD 2021
Fresenius Medical Care AG & Co KGaA, Recent Deals Summary
Section 5 – Company’s Recent Developments
Apr 13, 2021: Fresenius Medical Care opens new technology center in Schweinfurt for developing dialysis machines
Mar 12, 2021: Fresenius Medical Care makes company’s dialysis clinics available for vaccinating patients against COVID-19
Feb 23, 2021: Fresenius Medical Care achieves 2020 targets, expects significant COVID-19 impact in 2021 and confirms 2025 outlook
Feb 01, 2021: Fresenius Medical Care anticipates significant negative impact on 2021 net income from accelerated COVID-19 related excess mortality of dialysis patients; confirms mid-term targets
Jan 11, 2021: Fresenius Medical Care’s Frenova enrolls patients in initiative to build world’s largest genomic registry targeting kidney disease
Dec 14, 2020: Fresenius Medical Care improves in climate and water ranking
Dec 07, 2020: Fresenius Medical Care employee in Schweinfurt is Germany’s best apprentice in her specialty as electronics technician
Oct 29, 2020: Fresenius continues to demonstrate resilience amid the COVID-19 pandemic: FY/20 guidance confirmed given accelerated earnings growth in Q3
Oct 29, 2020: Fresenius Medical Care continues solid revenue and strong earnings growth in the third quarter
Oct 13, 2020: Fresenius announces changes to Supervisory Board
Section 6 – Appendix
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer

List of Tables
Fresenius Medical Care AG & Co KGaA, Key Facts
Fresenius Medical Care AG & Co KGaA, Key Employees
Fresenius Medical Care AG & Co KGaA, Key Employee Biographies
Fresenius Medical Care AG & Co KGaA, Major Products and Services
Fresenius Medical Care AG & Co KGaA, History
Fresenius Medical Care AG & Co KGaA, Subsidiaries
Fresenius Medical Care AG & Co KGaA, Key Competitors
Fresenius Medical Care AG & Co KGaA, Ratios based on current share price
Fresenius Medical Care AG & Co KGaA, Annual Ratios
Fresenius Medical Care AG & Co KGaA, Annual Ratios (Cont...1)
Fresenius Medical Care AG & Co KGaA, Annual Ratios (Cont...2)
Fresenius Medical Care AG & Co KGaA, Interim Ratios
Fresenius Medical Care AG & Co KGaA, Pharmaceuticals & Healthcare, Deals By Year, 2015 to YTD 2021
Fresenius Medical Care AG & Co KGaA, Pharmaceuticals & Healthcare, Deals By Type, 2015 to YTD 2021
Fresenius Medical Care AG & Co KGaA, Recent Deals Summary
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

★海外企業調査レポート[Fresenius Medical Care AG & Co KGaA (FME):企業の財務・戦略的SWOT分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • President Energy PLC (PPC):企業の財務・戦略的SWOT分析
    President Energy PLC (PPC) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesse …
  • Ames Construction Inc:企業の戦略的SWOT分析
    Ames Construction Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and …
  • Hoag Hospital Foundation:企業の戦略的SWOT分析
    Hoag Hospital Foundation - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products a …
  • Chiyoda Corp (6366):企業の財務・戦略的SWOT分析
    Chiyoda Corp (6366) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and t …
  • DNB ASA:企業の戦略・SWOT・財務情報
    DNB ASA - Strategy, SWOT and Corporate Finance Report Summary DNB ASA - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, pr …
  • Adamas Pharmaceuticals Inc (ADMS):製薬・医療:M&Aディール及び事業提携情報
    Summary Adamas Pharmaceuticals Inc (Adamas Pharmaceuticals) is a pharmaceutical company that develops and commercializes therapeutics for chronic disorders of the central nervous system. The company's Gocovri, formerly ADS-5102, is an amantadine extended-release (XR) formulation for the treatment fo …
  • GridEdge Networks Inc.:企業の戦略的SWOT分析
    GridEdge Networks Inc. - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and …
  • Air Lease Corporation:企業の戦略・SWOT・財務情報
    Air Lease Corporation - Strategy, SWOT and Corporate Finance Report Summary Air Lease Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • General Motors Company:企業の戦略・SWOT・財務情報
    General Motors Company - Strategy, SWOT and Corporate Finance Report Summary General Motors Company - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …
  • The SPAR Group Limited:企業の戦略・SWOT・財務情報
    The SPAR Group Limited - Strategy, SWOT and Corporate Finance Report Summary The SPAR Group Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …
  • Ithaca Energy Inc. (IAE)-石油・ガス分野:企業M&A・提携分析
    Summary Ithaca Energy Inc. (Ithaca) is an oil and gas company, which explores for, develops, and produces oil and gas in the North Sea. It focuses on the appraisal and development of undeveloped discoveries and the exploitation of its existing UK producing asset portfolio. The company has a portfoli …
  • Ubiquiti Networks Inc:企業の戦略・SWOT・財務情報
    Ubiquiti Networks Inc - Strategy, SWOT and Corporate Finance Report Summary Ubiquiti Networks Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • Turkish Aerospace Industries Inc:企業の戦略・SWOT・財務分析
    Turkish Aerospace Industries Inc - Strategy, SWOT and Corporate Finance Report Summary Turkish Aerospace Industries Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, produ …
  • PetroChina Co Ltd (857)-石油・ガス分野:企業M&A・提携分析
    Summary PetroChina Company Limited (PetroChina), a subsidiary of China National Petroleum Corporation, is an oil and gas company that explores for, develops and produces crude oil and natural gas; refines crude oil and petroleum products; and produces and sells basic and derivative chemical products …
  • BioRestorative Therapies Inc (BRTX)-医療機器分野:企業M&A・提携分析
    Summary BioRestorative Therapies Inc (BRT), formerly Stem Cell Assurance Inc is a developer of therapeutic products and medical therapies. The company performs stem cell programs which include brtxDISC and ThermoStem. brtxDISC,a lead therapeutic product, is designed to offer a non-surgical treatment …
  • Noble Energy Inc Oil & Gas Exploration and Production Operations and Cost Analysis – Q4, 2017
    Noble Energy Inc Oil & Gas Exploration and Production Operations and Cost Analysis - Q4, 2017 Summary Noble Energy Inc (Noble) is an independent energy company that explores for and produces crude oil, natural gas and natural gas liquids (NGLs). The company’s portfolio includes both US unconventiona …
  • Emergent BioSolutions Inc (EBS):医療機器:M&Aディール及び事業提携情報
    Summary Emergent BioSolutions Inc (Emergent) is a life sciences company. It focuses on protecting and enhancing life by providing specialized products to governments and healthcare providers. The company develops specialty products targeting public health threats and emerging infectious diseases. It …
  • Kiwibank Limited:企業の戦略・SWOT・財務情報
    Kiwibank Limited - Strategy, SWOT and Corporate Finance Report Summary Kiwibank Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and cor …
  • Hikma Pharmaceuticals Plc (HIK):企業の財務・戦略的SWOT分析
    Hikma Pharmaceuticals Plc (HIK) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weak …
  • Xylem Inc (XYL):企業の財務・戦略的SWOT分析
    Xylem Inc (XYL) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the p …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆